Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/6/2008

p>

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

GAAP net income $60.3 $36.4 $110.9 $68.0

Plus:

Interest expense 6.9 11.5 13.7 25.4

Interest income (1.7) (1.8) (4.0) (4.7)

Provision for income taxes 35.6 21.0 66.7 41.0

Depreciation (2008 includes

accelerated depreciation) 22.4 19.5 44.2 37.5

Amortization 20.2 44.1 40.4 88.1

EBITDA 143.7 130.7 271.9 255.3

Adjusted for:

Share-based compensation 4.9 3.5 9.3 6.9

Acquisition and licensing charges 0.5 2.2 5.5 9.6

Legal settlement (15.0) (0.8) (15.0) 0.2

Loss on early extinguishment of

debt - 1.7 1.1 4.4

Global supply chain initiative 3.4 - 15.4 -

Gain on sale of assets - (0.7) (1.4) (2.5)

Adjusted EBITDA $137.5 $136.6 $286.8 $273.9

The following table presents a reconciliation of forecasted net income for the 12 months ending December 31, 2008 to adjusted net income and adjusted earnings per diluted share:

Table 6

Watson Pharmaceuticals, Inc.

Reconciliation Table - Forecasted Adjusted Earnings per Diluted Share

(Unaudited; in millions except per share amounts)

Forecast for Twelve M
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
4. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
6. Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
7. Watson Files FDA Application for Generic LYBREL(R)
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... A new infographic compiles useful information about ... to learn how Apple’s new framework can change the ... ideal since Apple made Research Kit available ... framework for developing medical research apps that Apple announced ... to collect secure clinical data and communicate via subjects’ ...
(Date:4/16/2015)... 16, 2015 Avelas Biosciences, an in ... surgeries, announced today that it has initiated a Phase ... in women with primary, non-recurrent breast cancer undergoing surgery. ... the addition of Steven Chen , M.D., as ... label, dose escalation study will enroll up to 39 ...
(Date:4/16/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), ... cancer therapies in new orphan drug indications, today announced ... been added as a clinical trial site for the ... with refractory glioblastoma multiforme (GBM), the most common and ...
(Date:4/16/2015)... 2015 Dana-Farber Cancer Institute and ... Resolution Bioscience, Inc. today announced the successful completion ... blood-based, clinic ready, Next Generation Sequencing (NGS) assay ... is the first to demonstrate the successful sequencing ... in blinded plasma samples and highlights the ability ...
Breaking Biology Technology:Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
... CAMBRIDGE, England, October 12 Crescendo Biologics,("Crescendo") today ... to advance the development of its fragment antibody technology,platforms. ... Paris-based,venture capital firm, with Aitua, Avlar BioVentures and the ... Crescendo brings together highly innovative in vivo and in ...
... , SAN FRANCISCO, Oct. 12 Dr. Michael ... implant inventor, brain plasticity expert and ... Medicine (IOM) today in Washington, D.C. Also a member of ... a small group of scientists and doctors in the U.S. ...
... ANA, Calif., Oct. 12 Selexis SA ("Selexis") and ... present results of a recent collaborative effort combining the ... IS CHO Culture System, demonstrating the rapid production of ... cell lines. Irvine and Selexis will jointly present ...
Cached Biology Technology:Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 2Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 3Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 4Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 2Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 3Irvine Scientific and Selexis to Announce Results of Successful Collaboration 2
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update ... Wocket smart wallet. SoundView was one of the selected user groups ... the Wocket in multiple scenarios and outlets. ... retailers, making both debit and credit card payments.  ... the company meets their plans in 2015, it would push ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Hand Geometry - Global Strategic Business Report" report to ... for Hand Geometry in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... The 2007 American College of Neuropsychopharmacology Annual Meeting will ... from the worlds leading scientists. Presentations include innovative ... disorder, autism and addiction. SELECTED PANELS ... Cancer and Schizophrenia A series of studies elucidates evidence ...
... FOR IMMEDIATE RELEASE First identification of blood on ... Scientists in France are reporting for the first time that ... once the source of almost half the worlds gold ... their works of art. In a study scheduled for the ...
... numerals that is superior to that of human adults, ... Biology, a publication of Cell Press. There are ... humans are superior to chimpanzees in all cognitive functions, ... imagine that chimpanzeesyoung chimpanzees at the age of fivehave ...
Cached Biology News:New studies on schizophrenia, depression, trauma and autism highlight annual meeting 2New studies on schizophrenia, depression, trauma and autism highlight annual meeting 3American Chemical Society's Weekly PressPac -- Nov. 28, 2007 2American Chemical Society's Weekly PressPac -- Nov. 28, 2007 3American Chemical Society's Weekly PressPac -- Nov. 28, 2007 4American Chemical Society's Weekly PressPac -- Nov. 28, 2007 5American Chemical Society's Weekly PressPac -- Nov. 28, 2007 6American Chemical Society's Weekly PressPac -- Nov. 28, 2007 7American Chemical Society's Weekly PressPac -- Nov. 28, 2007 8Young chimps top adult humans in numerical memory 2
Request Info...
... Services include: ,ISH Protocol Development ... Analyses ,RNA and DNA Screenings ... and Tissues ,Double Labeling of ... and Tissues ,RNA and DNA ...
Request Info...
... Quality ISO 9001:2000 Certified USDA Research ... Validated, SOP's Training AALAS Certified ... All Procedures GLP Documentation Upon Request ... shopping point for all your custom immunology ...
Biology Products: